Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Activated partial thromboplastin time, Alanine aminotransferase, Arrhythmia, Aspartate aminotransferase, Asthenia, Blood alkaline phosphatase, Blood bicarbonate, Blood bilirubin, Blood chloride, Blood creatinine, Blood glucose, Blood potassium, Blood sodium, Blood urea, Body temperature, Bradycardia, C-reactive protein, Chest pain, Chills, Cough, Delirium, Dyspnoea, Fibrin D dimer, Gamma-glutamyltransferase, Haematocrit, Haemoglobin, Heart rate, Hypokalaemia, Hypoxia, International normalised ratio, Jaundice, Lymphocyte count, Nervousness, Neutrophil count, Oxygen saturation, Oxygen saturation decreased, PCO2, Platelet count, PO2, Pyrexia, Respiratory acidosis, Respiratory failure, Restlessness, Sepsis, Ventricular tachycardia, White blood cell count, Decreased appetite, Troponin, Blood pH, Investigation, Procalcitonin, N-terminal prohormone brain natriuretic peptide, Blood pressure measurement, Multiple organ dysfunction syndrome, SARS-CoV-2 test, COVID-19 pneumonia
Life Threatening? Yes
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:
Write-up: Respiratory failure; COVID-19 pneumonia; dyspnoea; bronchial pain; restlessness; hyposaturation; Jaundice; Nervous; respiratory acidosis; hypokalaemia; Septic condition; delirium; This is a spontaneous report from a contactable consumer downloaded from the Regulatory Authority CZ-CZSUKL-21000604. An 88-year-old male patient received the first dose of bnt162b2 (COMIRNATY), intramuscularly on 21Jan2021 at single dose for COVID-19 immunisation. Medical history included arterial hypertension on therapy since 1988, ischemic heart disease, st.p. selective coronagraphy in Sep2005, 2x stent into the right coronary artery, normal kinetics and left ventricular ejection fraction, St.p. collapse state in Nov2000, insufficiency in the vertebrobasilar basin, hypercholesterolemia on therapy, St.p. transurethral resection, perhaps benign small bladder polyps, vesical polyp, hypertrophy of the prostate on therapy, St.p. haemorrhoid surgery in 1983, ex-smoker from about 60 years, previously 20 cig/d, alcohol occasionally, and without allergies. Family history was insignificant. Concomitant medications included perindopril arginine (PRESTARIUM NEO), acetylsalicylic acid (ANOPYRIN), tamsulosin, citalopram hydrobromide (APO-CITALOPRAM), and atorvastatin calcium (SORTIS). The patient experienced respiratory failure in Feb2021, COVID-19 pneumonia on 26Jan2021, and fever 38 ?c to 39 ?c on 26Jan2021. The patient died on the 13Feb2021 because of respiratory failure. Since the 5th day after the vaccination on 26Jan2021, the patient developed increasing body temperature up to fever 39?C, rigoring, inappetence, weakness and cough. From the general practitioner, he received a prescription for erdosteine (ERDOMED). Next dyspnoea and bronchial pain during coughing added. In the beginning, he was in the care of his family. On 06Feb2021 he was hospitalized via ambulance for bilateral COVID pneumonia. On 06Feb2021 on receipt, he had saturation 75% with the need of the oxygen therapy by half mask with a reservoir. Antiviral therapy was not started. Laboratory mild lymphopenia - administered Isoprinosine, hypokalaemia, CRP elevation, no leukocytosis, elevated D-dimers. Initiated therapy with systemic corticosteroids, therapeutic dose with low molecular weight heparins. For mask intolerance, on 09Feb2021 was initiated HFNO (high-flow oxygen therapy). For significant restlessness and numerous episodes of hyposaturation the patient was transferred to the ICU. Ventilation and circulation stable during transport. Admission to the ICU was ventilating sufficient to support O2 goggles at a dose of 6 l/min, a continuation of potassium correction and set therapy. On 10Feb2021, persistent deliriant state, the necessity of pharmacological sedation with dexmetonidine, the tendency to bradycardia at higher doses, a single administration of atropine. Furthermore, runs of transient ventricular tachycardia, administered amiodarone with effect. Due to progressive respiratory insufficiency continued HFNO. Tazobactam + amikacin was empirically administered for the elevation of inflammatory parameters (from 11Feb2021 only tazobactam monotherapy). On 11Feb2021, progressive respiratory insufficiency, laboratory elevation of inflammatory parameters. For significant discomfort, pain and dyspnea of the patient, continuous opiates were started. The patient died on the 13Feb2021. An autopsy was not indicated. New or worsening symptoms during Covid-19 disease: Multiorgan failure, respiratory, dyspnea, hypoxemia, COVID pneumonia, respiratory failure, cardiovascular, arrhythmia-transient ventricular tachycardia, tendency to bradycardia, gastrointestinal/hepatic, jaundice-laboratory and icteric materials, slightly elevated Urea and Creatinine, nervous, altered state of consciousness-delirium, septic condition, respiratory acidosis, and hypokalaemia. Treatment for Covid-19: Corticosteroids (stop 11Feb2021 in sepsis), antibiotherapy (tazobactam + amikacin 10Feb2021, from 11Feb2021 only tazobactam), isoprenosine from 06Feb2021, Erdomed - from a general practitioner, atropine-10Feb2021 once for bradycardia, cordaorne-for runs of transient ventricular tachycardia from 10Feb2021, morphine-continuously from 11Feb2021, and infusion therapy and supportive therapy. The patient underwent lab tests and procedures which included activated partial thromboplastin time: 32.9 on 06Feb2021, alanine aminotransferase: 1.05 iu/l on 08Feb2021, aspartate aminotransferase: 1.06 iu/l on 08Feb2021, blood alkaline phosphatase: 1.2 iu/l on 08Feb2021, blood bicarbonate: 30.8 mmol/l on 09Feb2021, blood bicarbonate: 29.9 mmol/l on 09Feb2021, blood bicarbonate: 24.7 mmol/l on 12Feb2021, blood bicarbonate: 29.8 mmol/l on 12Feb2021, blood bilirubin: 21 umol/l on 10Feb2021, blood chloride: 88 mmol/l on 06Feb2021, blood creatinine: 77 umol/l on 08Feb2021, blood creatinine: 180 umol/l on 12Feb2021, blood glucose: 6.6 mmol/l on 06Feb2021, blood glucose: 9.1 mmol/l on 10Feb2021, blood glucose: 8.3 mmol/l on 12Feb2021, Blood pH: 7,528 on 09Feb2021, 7,498 on 10Feb2021, 7,267 on 12Feb2021, Potassium: 2.9 mmol/L on 08Feb2021, 4.3 mmol/L on 12Feb2021, Potassium: 3.7 mol/L on 06Feb2021, Blood pressure: 120/80 mmHg on 06Feb2021, Sodium: 136 mmol/L 06Feb2021, 151 mmol/L 12Feb2021, Urea: 11.7 mmol/L on 08Feb2021, 15.2 mmol/L on 12Feb2021, Body temperature: <=39 Centigrade on 26Jan2021, 36.3 Centigrade on 06Feb2021, C-reactive protein: 160 mg/l on 06Feb2021, 88.8 mg/l on 08Feb2021, 199.5 mg/l on 10Feb2021, 262.2 mg/l on 10Feb2021, 222.5 mg/l on 12Feb2021, Fibrin D dimer: 1890 mg/l on 06Feb2021, GGTP: 1.32 IU/l on 08Feb2021, Hematocrit: 0.44 on 06Feb2021, Hemoglobin: 149 g/l on 06Feb2021, 124 g/l on 12Feb2021, Pulse rate: 58 Units/min on 06Feb2021, International normalised ratio: 0.99 on 06Feb2021, Lymphocytes: 2.8% on 12Feb2021, Lymphocytes: 0.61 x10 9/l on 06Feb2021, 0.6 x10 9/l on 08Feb2021, 0.43 x10 9/l on 12Feb2021, Netrophils absolutely: 14.56 on 12Feb2021, Neutrophils: 94.7% on 12Feb2021, Neutrophils: 9.79 x10 9/l on 08Feb2021, 14.56 x10 9/l on 12Feb2021, NT-proBNP: 4583 pg/mL on 10Feb2021, O2 saturation: 75% on 06Feb2021, 94% 8l/min on 06Feb2021, 69.5% on 12Feb2021, Partial pressure CO2: 12 on 09Feb2021, 9 kPa on 12Feb2021, Thrombocyte count: 221 x10 9/l on 06Feb2021, 271 x10 9/l on 12Feb2021, Partial pressure O2: 12 on 09Feb2021, 6.1 kPa on 12Feb2021, Procalcitonin: 0.24 ug/L on 10Feb2021, Ag-SARS-Cov2: positive on 10Feb2021, PCR SARS-CoV2: positive on 06Feb2021, Troponin: 60 ng/L on 06Feb2021, Leukocytes: 15.38 on 12Feb2021, WBC: 7.92 x10 9/l on 06Feb2021, 10.67 x10 9/l on 08Feb2021, and 15.38 x10 9/l on 12Feb2021. Other relevant examinations: microbiological examination of Legionella + Penumococcus negative on an unspecified date. The patient died on 13Feb2021. An autopsy was not performed. No follow-up attempts possible. No further information expected. Batch/Lot number cannot be obtained.; Reported Cause(s) of Death: COVID-19 pneumonia; Respiratory failure.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166